▶ Choose a source :  
▶ Sort by :   Latest News ▶ Most read in the last :   1 Hour 2 Hours 4 Hours 12 Hours 24 Hours

: SALEM, Ore. (AP) - When an errant baseball hit her in the face years ago, Fatima Preciado's lip split. Soon, the 8-year-old's cut became infected. Preciado's ...

: COLUMBUS, Ohio (AP) — The Latest on a lawsuit challenging the constitutionality of Ohio's lethal injection system (all times local): 9:45 a.m. A federal...

: COPENHAGEN, Denmark (AP) — A resident in Arctic Norway says four adults and two children were inside a house when an avalanche...

: Interested in a career in recruitment and looking to work with a company who do something a bit different CK Group is recruiting for Trainee... ......

: Nativis Rounds Out Board of Directors with Appointment of Dr. Una Ryan Nativis Inc. Nativis Inc. ......

: CEL-SCI Scientist Presents New Findings for Rheumatoid Arthritis Treatment Vaccine at Conference ... CEL-SCI Corporation ......

: Interested in developing your career in recruitment and looking to work with a company who do something a bit different CK Group is recruiting for... ......

: H3 Biomedicine Announces Appointment of Peter G. Smith, Ph. D. H3 Biomedicine ......

: N-of-One® Dramatically Speeds High-Accuracy Interpretation of the Illumina TrueSight Tumor170 Cancer Panel ...

: Anders Hove, MD Joins ARCA biopharma Board of Directors ARCA biopharma, Inc. ARCA biopharma, Inc. ......

: Two Pore Guys to Present at Point-of-Care Diagnostics Symposium at the Molecular Medicine Tri-Conference ... Two Pore...

: PrescribeWellness Shows Continued Growth with Two Key Appointments PrescribeWellness, ... PrescribeWellness ......

: Sarepta Therapeutics Agrees to Sale of Priority Review Voucher for $125M Sarepta Therapeutics... Sarepta Therapeutics, Inc. ......

: Catherine D. Strader, Ph.D. Acorda Therapeutics, Inc. ......

: Second Sight Announces Professor Stanislao Rizzo Has Completed His 30th Implant of the Argus II Retinal Prosthesis ... Second...

: Pfizer Announces Acceptance of Regulatory Submission for Inotuzumab Ozogamicin by the U.S. Pfizer Inc...

: Selexis SA Inks Agreement for Applications in Cancer and Infectious Disease Selexis ... Selexis SA ......

: VBL Therapeutics Reports Full Data for VB-111 Monotherapy in Phase 2 Trial for Recurrent Thyroid Cancer TEL AVIV, Israel,...

: Actinium Pharmaceuticals Announces Hiring of Steven Price to Position of Vice President, Clinical and...

: Trevena Announces Positive Top-line Results from Two Phase 3 Pivotal Efficacy Studies of Intravenous...

: Market Research and Forecast of Antineoplastic Drugs in China 2016-2021 - Market will Reach More than RMB250 Billion -...

: Edge Therapeutics Appoints Alyssa Wyant as Senior Vice President, Regulatory Affairs and Makes Inducement...

: Bellicum Announces Initiation of Patient Dosing with Controllable CAR T-Cell Product Candidate HOUSTON, Feb. ......

: Amphastar Announces the Receipt of a CRL for Intranasal Naloxone for the Emergency Treatment of Opioid Overdose RANCHO CUCA... ...

: Stemline Therapeutics Provides Update on Clinical Programs NEW YORK, Feb. ......

: Cellect Announces Positive Clinical Trial Results ApoGraft TM, Cellect’s flagship technology, validated as safe, robust and... ......

: Cerus to Release Fourth Quarter and Year End 2016 Results on March 7, 2017 Cerus Corporation ... Cerus Corporation ......

: EpiCast Report: Myelofibrosis - Epidemiology Forecast to 2025 - Research and Markets Resear... Research and Markets ......

: Protalex Provides Update on US and EU Studies of PRTX-100 to Treat Immune Thrombocytopenia Pr... Protalex, Inc. ......

: PetLife Pharmaceutical Taps National Public Relations Firm to Help Bring to Market Cancer Treatment Originally...
About newsoneplace.com - Privacy & Terms -
Copyright © 2015 www.newsoneplace.com